COMMUNIQUÉS West-GlobeNewswire

-
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
06/02/2024 -
Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
06/02/2024 -
Linnea SA of Switzerland and Universidade Estadual de Campinas (Unicamp) Brazil announce scientific partnership to promote cannabinoids research
06/02/2024 -
La société suisse Linnea SA et Universidade Estadual de Campinas (Unicamp) Brésil annoncent un partenariat scientifique pour promouvoir la recherche sur les cannabinoïdes
06/02/2024 -
MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS
06/02/2024 -
nuEra Cannabis Becomes a Vertically Integrated Illinois Powerhouse with Ieso Acquisition
06/02/2024 -
INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
06/02/2024 -
Nudj Health Expands Virtual Cardiac Rehab Services to Patients with Ornish Lifestyle Medicine by Sharecare
06/02/2024 -
Philips Sounds transform the sound of care, reducing patient monitoring alarm noise by up to 66%
06/02/2024 -
Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
06/02/2024 -
Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain
06/02/2024 -
New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
06/02/2024 -
GRANT OF PERFORMANCE SHARE UNITS
06/02/2024 -
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
06/02/2024 -
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/02/2024 -
Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs
06/02/2024 -
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
06/02/2024 -
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
06/02/2024 -
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
06/02/2024
Pages